Perplexit

While there is great uncertainty about the impact of a Brexit on British life sciences companies, the problems posed to the European regulatory system are clearer. Brexit could slash or eliminate MHRA's role in EMA, drying up one of the agency's biggest pools of scientific and regulatory expertise.

Among the many perplexing challenges for the EU, figuring out how to replace MHRA experts may be among the most pressing. ...